Predictions and Changes

Premium

It’s a prediction we’ve all heard before: when sequencing got cheap enough, prognosticators said, scientists would abandon their microarrays entirely. We’d all be using chip scanners for doorstops.

In our cover story, we follow up on that prediction to see if arrays really are spiraling into obsolescence. It turns out that while next-gen sequencing has taken away — apps like ChIP appear set for a sequencer-only world — it has also given, creating demand for arrays in new sample prep and validation techniques.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.